High-Risk Localized and Locally Advanced Prostate Cancer

Around 20%–30% of nonmetastatic prostate cancer patients have high-risk localized disease. The best treatment for high-risk localized disease is still unclear, and the reliability of the definition of “high-risk” may need to be validated first. Although recent advances in radiotherapy for prostate c...

Olles dieđut

Bibliográfalaš dieđut

Materiálatiipa:	Online
Giella:	eaŋgalasgiella
Almmustuhtton:	MDPI - Multidisciplinary Digital Publishing Institute 2023
Fáttát:	imaging modality &nbsp oligometastasis radical prostatectomy lymph node dissection brachytherapy hormonal therapy neoadjuvant/adjuvant therapy quality of life local invasion thema EDItEUR::T Technology, Engineering, Agriculture, Industrial processes::TB Technology: general issues thema EDItEUR::T Technology, Engineering, Agriculture, Industrial processes::TC Biochemical engineering::TCB Biotechnology
Liŋkkat:	ONIX_20230808_9783036581682_54
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!